Article Information
History
- May 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nafisa Wadud1,2,
- Naim Ahmed1,2,
- Mannu Shergil1,2,
- Maida Khan1,2,
- Murali Krishna1,3,*,
- Aamir Gilani1,3,
- Samer El Zarif1,3,
- Jodi Galaydick1,3,
- Karthika Linga1,3,
- Shravan Koor1,3,
- Julia Galea1,4,
- Lauren Stuczynski1,4 and
- Maria B Osundele1,4
- 1Orange Regional Medical Center (All authors)
- 2Department of Internal Medicine
- 3Department of Pulmonary, Critical Care and Sleep Medicine
- 4Department of Pharmacy
- ↵*Please address correspondence to: Murali G. Krishna, MD mkrishna{at}ghvhs.org
Posted May 16, 2020.
Improved survival outcome in SARs-CoV-2 (COVID-19) Acute Respiratory Distress Syndrome patients with Tocilizumab administration
